Figure 4
Figure 4. Newly generated iTreg cells protect from autoimmunity. (A) DC-tg Rag2−/− (DC-tg) or Rag2−/− control (ntg) mice were adoptively transferred with polyclonal CD4+ DEREG T cells. Three weeks after transfer, recipient mice treated or not with diphtheria toxin were infected with HSV-1 and incidence and severity of the disease scored on days 7 and 10 after treatment. Note that deletion of Foxp3+ cells in the recipient DC-tg mice makes them strongly susceptible to HSK. Data are mean ± SEM of 6 mice per group. (B) Left panels: percentage of CD25+Foxp3+ on CD4+CD45+ cells present in the corneas of DC-tg Rag2−/− (DC-tg) or Rag2−/− (ntg) recipient mice at day 10 after HSV-1 ocular infection. Right panel: quantification of the cytofluorimetric analysis. Data are mean ± SEM calculated on 3 different mice. ****P < .001.

Newly generated iTreg cells protect from autoimmunity. (A) DC-tg Rag2−/− (DC-tg) or Rag2−/− control (ntg) mice were adoptively transferred with polyclonal CD4+ DEREG T cells. Three weeks after transfer, recipient mice treated or not with diphtheria toxin were infected with HSV-1 and incidence and severity of the disease scored on days 7 and 10 after treatment. Note that deletion of Foxp3+ cells in the recipient DC-tg mice makes them strongly susceptible to HSK. Data are mean ± SEM of 6 mice per group. (B) Left panels: percentage of CD25+Foxp3+ on CD4+CD45+ cells present in the corneas of DC-tg Rag2−/− (DC-tg) or Rag2−/− (ntg) recipient mice at day 10 after HSV-1 ocular infection. Right panel: quantification of the cytofluorimetric analysis. Data are mean ± SEM calculated on 3 different mice. ****P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal